Literature DB >> 10740126

Design and interpretation of equivalence trials.

T R Fleming1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10740126     DOI： 10.1016/s0002-8703(00)90067-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  5 in total

1.  Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial.

Authors:  Margaret V Ragni
Journal:  Expert Rev Hematol       Date:  2011-10       Impact factor: 2.929

2.  The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulants.

Authors:  Grace Wangge; Kit C B Roes; Anthonius de Boer; Arno W Hoes; Mirjam J Knol
Journal:  CMAJ       Date:  2012-08-20       Impact factor: 8.262

3.  Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs.

Authors:  Scott D Halpern; Peter A Ubel; Jesse A Berlin; Raymond R Townsend; David A Asch
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

4.  Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-08-17

5.  Interval exercise versus continuous exercise in patients with moderate to severe chronic obstructive pulmonary disease--study protocol for a randomised controlled trial [ISRCTN11611768].

Authors:  Milo A Puhan; Gilbert Büsching; Evelien VanOort; Christian Zaugg; Holger J Schünemann; Martin Frey
Journal:  BMC Pulm Med       Date:  2004-08-13       Impact factor: 3.317
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.